Advanced search

Project: A double-blind placebo-controlled study to assess the effects of MK-449 on recurrent tachyarrhythmias with implanted cardioverter defibrillators.

01-JAN-00 – 31-DEC-99

Double-blind study to assess the impact of a new class III anti-arrhythmicum drug on quality of life and conventional endpoints as frequent shocks, sudden death and overall mortality in patients who are treated with an internal cardioverter defibrillilator.